Xbrane Biopharma AB (publ) (STO:XBRANE)
Sweden · Delayed Price · Currency is SEK 10.70
+0.40 (3.88%)
Jun 11, 2026, 5:29 PM CET
Xbrane Biopharma AB Market Cap
Xbrane Biopharma AB has a market cap or net worth of 220.48 million as of June 11, 2026. Its market cap has decreased by -39.44% in one year.
Market Cap
220.48M
Enterprise Value
210.61M
Revenue
76.45M
Ranking
n/a
PE Ratio
2.08
Stock Price
10.70
Market Cap Chart
Since February 3, 2016, Xbrane Biopharma AB's market cap has increased from 131.05M to 220.48M, an increase of 68.24%. That is a compound annual growth rate of 5.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 11, 2026 | 220.48M | 4.90% |
| Dec 30, 2025 | 210.17M | -14.54% |
| Dec 30, 2024 | 245.94M | -17.28% |
| Dec 29, 2023 | 297.31M | -86.83% |
| Dec 30, 2022 | 2.26B | -13.94% |
| Dec 30, 2021 | 2.62B | 58.03% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sprint Bioscience AB | 345.04M |
| Mendus AB | 312.88M |
| Isofol Medical AB | 224.99M |
| Nanologica AB | 182.80M |
| Initiator Pharma | 179.35M |
| Diamyd Medical AB | 172.65M |
| Xintela AB | 172.25M |
| Active Biotech AB | 167.92M |